GYPB and metabolic dysfunction-associated steatotic liver disease: To gain mechanistic insights into the signaling pathways responsible for the effects of Gyp in NAFLD, we evaluated the mRNA and protein expression of several molecules associated with lipid metabolism in different liver tissues.